Krystal Biotech buy Guggenheim
Start price
25.02.26
/
50%
€233.30
Target price
25.02.27
€240.95
Performance (%)
29.75%
Price
19.06.26
€302.70
Summary
This prediction is currently active. The BUY prediction by Guggenheim currently has a performance of 29.75%. This prediction currently runs until 25.02.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 10.113% | 10.113% |
| iShares Core DAX® | 1.352% | 2.740% |
| iShares Nasdaq 100 | 3.277% | 6.507% |
| iShares Nikkei 225® | 7.434% | 17.832% |
| iShares S&P 500 | 1.702% | 3.099% |
Comments by Guggenheim for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (KRYS) had its price target raised by Guggenheim from $224.00 to $284.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Guggenheim for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€120.90
07.05.25
07.05.25
€166.60
07.05.26
07.05.26
113.56%
08.05.26
08.05.26
Krystal Biotech
Start price
Target price
Perf. (%)
€152.00
27.02.24
27.02.24
€161.18
27.02.25
27.02.25
14.14%
28.02.25
28.02.25